{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:06:08Z","timestamp":1756339568240,"version":"3.44.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,27]]},"DOI":"10.7759\/cureus.91127","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:41:03Z","timestamp":1756316463000},"source":"Crossref","is-referenced-by-count":0,"title":["Eclampsia and Neonatal Loss in a Patient With Primary Antiphospholipid Syndrome, Factor V Leiden, and Methylenetetrahydrofolate Reductase (MTHFR) Mutations: A Rare Thrombophilic Triad"],"prefix":"10.7759","author":[{"given":"Sara","family":"Hachem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oussama","family":"Fakih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Abi Dargham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouidade","family":"Aitisha Tabesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis S","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4:295-306. 10.1111\/j.1538-7836.2006.01753.x","journal-title":"J Thromb Haemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina RM","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, et al.. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994, 369:64-7. 10.1038\/369064a0","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01141.x","article-title":"Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies","volume":"3","author":"Den Heijer M","year":"2005","unstructured":"Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005, 3:292-9. 10.1111\/j.1538-7836.2005.01141.x","journal-title":"J Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-009-0356-9","article-title":"The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome","volume":"29","author":"Diz-Kucukkaya R","year":"2010","unstructured":"Diz-Kucukkaya R, Hancer VS, Artim-Esen B, Pekcelen Y, Inanc M. The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome. J Thromb Thrombolysis. 2010, 29:303-9. 10.1007\/s11239-009-0356-9","journal-title":"J Thromb Thrombolysis"},{"key":"ref5","article-title":"Mutation of a 5,10-methylenetetrahydrofolate reductase gene in systemic lupus erythematosis and antiphospholipid syndrome","volume":"74","author":"Reshetniak TM","year":"2002","unstructured":"Reshetniak TM, Patrushev LI, Tikhonova TF, et al.. Mutation of a 5,10-methylenetetrahydrofolate reductase gene in systemic lupus erythematosis and antiphospholipid syndrome. Ter Arkh. 2002, 74:28-32.","journal-title":"Ter Arkh"},{"key":"ref6","article-title":"Screening for inherited thrombophilia: indications and therapeutic implications","volume":"87","author":"De Stefano V","year":"2002","unstructured":"De Stefano V, Rossi E, Paciaroni K, et al.. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica. 2002, 87:1095-108.","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab010","article-title":"Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis","volume":"36","author":"Liu X","year":"2021","unstructured":"Liu X, Chen Y, Ye C, et al.. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod. 2021, 36:1213-29. 10.1093\/humrep\/deab010","journal-title":"Hum Reprod"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002534","article-title":"Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study","volume":"9","author":"Laurent C","year":"2023","unstructured":"Laurent C, Ricard L, Nguyen Y, et al.. Triple positive profile in antiphospholipid syndrome: prognosis, relapse and management from a retrospective multicentre study. RMD Open. 2023, 9:4. 10.1136\/rmdopen-2022-002534","journal-title":"RMD Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.646846","article-title":"Longitudinal analysis of anti-cardiolipin and anti-\u03b22-glycoprotein-I antibodies in recent-onset systemic lupus erythematosus: a prospective study in Swedish patients","volume":"8","author":"Frodlund M","year":"2021","unstructured":"Frodlund M, Walhelm T, Dahle C, Sj\u00f6wall C. Longitudinal analysis of anti-cardiolipin and anti-\u03b22-glycoprotein-I antibodies in recent-onset systemic lupus erythematosus: a prospective study in Swedish patients. Front Med (Lausanne). 2021, 8:646846. 10.3389\/fmed.2021.646846","journal-title":"Front Med (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2023.9260","article-title":"Association of MTHFR polymorphism, folic acid and vitamin B12 with serum homocysteine levels in pregnant women","volume":"24","author":"Bo\u0161kovi\u0107 A","year":"2024","unstructured":"Bo\u0161kovi\u0107 A, \u0106uk A, Mandrapa V, et al.. Association of MTHFR polymorphism, folic acid and vitamin B12 with serum homocysteine levels in pregnant women. Biomol Biomed. 2024, 24:138-43. 10.17305\/bb.2023.9260","journal-title":"Biomol Biomed"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-023-00349-4","article-title":"Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease","volume":"7","author":"Zanussi JT","year":"2023","unstructured":"Zanussi JT, Zhao J, Wei WQ, et al.. Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease. BMC Rheumatol. 2023, 7:24. 10.1186\/s41927-023-00349-4","journal-title":"BMC Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000493","article-title":"How to diagnose and manage antiphospholipid syndrome","volume":"2023","author":"Hubben A","year":"2023","unstructured":"Hubben A, McCrae KR. How to diagnose and manage antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2023, 2023:606-13. 10.1182\/hematology.2023000493","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref13","article-title":"Antiphospholipid syndrome during pregnancy: the state of the art","volume":"5","author":"Di Prima FA","year":"2011","unstructured":"Di Prima FA, Valenti O, Hyseni E, et al.. Antiphospholipid syndrome during pregnancy: the state of the art. J Prenat Med. 2011, 5:41-53.","journal-title":"J Prenat Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski A","year":"2009","unstructured":"Danowski A, de Azevedo MN, de Souza Papi JA, Petri M. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus. J Rheumatol. 2009, 36:1195-9. 10.3899\/jrheum.081194","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316640912","article-title":"Systematic review of case reports of antiphospholipid syndrome following infection","volume":"25","author":"Abdel-Wahab N","year":"2016","unstructured":"Abdel-Wahab N, Lopez-Olivo MA, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus. 2016, 25:1520-31. 10.1177\/0961203316640912","journal-title":"Lupus"},{"key":"ref16","article-title":"Case-control study of the frequency of thrombophilic disorders in women with late fetal loss and no prior thrombotic history","volume":"81","author":"Gris JC","year":"1999","unstructured":"Gris JC, Qu\u00e9r\u00e9 I, Monpeyroux F, et al.. Case-control study of the frequency of thrombophilic disorders in women with late fetal loss and no prior thrombotic history. Thromb Haemost. 1999, 81:891-6.","journal-title":"Thromb Haemost"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(02)00390-0","article-title":"Thrombophilia and pregnancy loss","volume":"108","author":"Brenner B","year":"2002","unstructured":"Brenner B. Thrombophilia and pregnancy loss. Thromb Res. 2002, 108:197-202. 10.1016\/s0049-3848(02)00390-0","journal-title":"Thromb Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108597","article-title":"Treatment of antiphospholipid syndrome","volume":"221","author":"Radin M","year":"2020","unstructured":"Radin M, Cecchi I, Rubini E, et al.. Treatment of antiphospholipid syndrome. Clin Immunol. 2020, 221:7. 10.1016\/j.clim.2020.108597","journal-title":"Clin Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379026-eclampsia-and-neonatal-loss-in-a-patient-with-primary-antiphospholipid-syndrome-factor-v-leiden-and-methylenetetrahydrofolate-reductase-mthfr-mutations-a-rare-thrombophilic-triad","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:41:04Z","timestamp":1756316464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379026-eclampsia-and-neonatal-loss-in-a-patient-with-primary-antiphospholipid-syndrome-factor-v-leiden-and-methylenetetrahydrofolate-reductase-mthfr-mutations-a-rare-thrombophilic-triad"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.91127","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}